Stockscreener 앱 받기
18.58
1.28%
-0.24
전일 마감가:
$18.82
열려 있는:
$18.67
하루 거래량:
513.61K
Relative Volume:
0.58
시가총액:
$2.06B
수익:
$418.33M
순이익/손실:
$-252.07M
주가수익비율:
-7.7417
EPS:
-2.4
순현금흐름:
$-238.84M
1주 성능:
+0.16%
1개월 성능:
+9.29%
6개월 성능:
-47.62%
1년 성능:
-26.79%
1일 변동 폭
$18.42
$18.86
1주일 범위
$18.01
$19.83
52주 변동 폭
$16.82
$44.34
Zai Lab Limited Adr Stock (ZLAB) Company Profile
명칭
Zai Lab Limited Adr
전화
862161632588
주소
899 HALEI ROAD, SHANGHAI
ZLAB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZLAB
Zai Lab Limited Adr
|
18.58 | 2.09B | 418.33M | -252.07M | -238.84M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-25 | 재개 | Jefferies | Buy |
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2025-03-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-12-14 | 개시 | Morgan Stanley | Overweight |
| 2023-08-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-01-21 | 개시 | Macquarie | Outperform |
| 2021-10-12 | 개시 | Bernstein | Mkt Perform |
| 2020-04-28 | 개시 | Goldman | Buy |
| 2020-04-15 | 개시 | Guggenheim | Buy |
| 2019-07-12 | 개시 | BofA/Merrill | Buy |
| 2019-07-05 | 개시 | Macquarie | Outperform |
| 2019-01-29 | 개시 | Credit Suisse | Outperform |
| 2018-11-21 | 개시 | Jefferies | Buy |
| 2018-06-21 | 재개 | Leerink Partners | Outperform |
| 2018-02-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2017-10-16 | 개시 | JP Morgan | Neutral |
| 2017-10-16 | 개시 | Leerink Partners | Outperform |
모두보기
Zai Lab Limited Adr 주식(ZLAB)의 최신 뉴스
Simply Good Foods (NASDAQ:SMPL) Stock Crosses Below 200-Day Moving Average – Time to Sell? - Defense World
Zai Lab (NASDAQ:ZLAB) Shares Gap UpWhat's Next? - MarketBeat
Zai Lab Highlights Strategic Priorities and Global Pipeline Progress at 44th Annual J.P. Morgan Healthcare Conference - Chartmill
UBS gives Zai Lab (ZLAB) a buy rating - MSN
Zai Lab (NASDAQ:ZLAB) Research Coverage Started at UBS Group - Defense World
UBS Gives Zai Lab (ZLAB) a Buy Rating - Insider Monkey
Zai Lab (ZLAB) Is Up 7.9% After First-In-China AUGTYRO Approval Across TRK TKI Settings - Sahm
Zai Lab Announces National Medical Products Administration (NMPA) Approval of AUGTYRO™ (repotrectinib) for Patients with NTRK-Positive Solid Tumors - BioSpace
China clears new AUGTYRO use for adults with NTRK‑positive cancers - Stock Titan
Zai Lab to Present at 44th Annual J.P. Morgan Healthcare Conference - BioSpace
The Truth About Zai Lab Ltd (ADR): Is This Sleeper Stock About To Explode Or Nah? - AD HOC NEWS
Zai Lab (NASDAQ:ZLAB) Insider Rafael Amado Sells 10,787 Shares - Defense World
The Truth About Zai Lab Ltd (ADR): Is This Sleeper Stock About To Explode Or Fade? - AD HOC NEWS
EBITDA per share of Zai Lab Ltd. Sponsored ADR – MUN:1ZL - TradingView — Track All Markets
Zai Lab Limited (ZLAB) Stock Surges After China Approves COBENFY for Schizophrenia: News, Forecasts, and Analyst Outlook on Dec. 24, 2025 - ts2.tech
FDA Asks Reviva Pharmaceuticals To Conduct Additional Phase 3 Study For Its Schizophrenia Drug - Sahm
Zai Lab Announces Approval of COBENFY (xanomeline and trospium chloride) in China, a First-in-Class Therapy for Schizophrenia - Business Wire
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
CapEx per share of Zai Lab Ltd. Sponsored ADR – MUN:1ZL - TradingView — Track All Markets
How Investors May Respond To Zai Lab (ZLAB) Advancing ZL-1503 Into Global Phase 1/1b Atopic Dermatitis Trial - Sahm
Zai Lab (NASDAQ:ZLAB) Hits New 12-Month LowTime to Sell? - MarketBeat
How Investors Are Reacting To Zai Lab (ZLAB) Advancing ZL-1503 And Securing Key NRDL Renewals - Sahm
Zai Lab (NASDAQ:ZLAB) Hits New 1-Year LowShould You Sell? - MarketBeat
Zai Lab Announces Dosing of First Participant in Global Phase 1/1b study of ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis - Business Wire
Zai Lab Announces Updates to China’s National Reimbursement Drug List - Business Wire
Zai Lab Limited (ZLAB) Moves 21.5% Higher: Will This Strength Last? - MSN
What Zai Lab (ZLAB)'s Q3 Results and Reaffirmed 2025 Guidance Mean for Shareholders - Sahm
Zai Lab (ZLAB) Remains a Buy Amid Strong Commercial and Pipeline Momentum - Finviz
Mitchells & Butlers (LON:MAB) Shares Up 7.2% – Should You Buy? - Defense World
Analysts Set Aardvark Therapeutics, Inc. (NASDAQ:AARD) PT at $30.63 - Defense World
Hamilton Insurance Group, Ltd. (NYSE:HG) Receives $28.63 Average Target Price from Brokerages - Defense World
Brokerages Set Circle Internet Group, Inc. (NYSE:CRCL) Price Target at $150.33 - Defense World
Analyzing YY Group (NASDAQ:YYGH) and Cintas (NASDAQ:CTAS) - Defense World
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Zai Lab (NASDAQ:ZLAB) Sees Strong Trading VolumeHere's Why - MarketBeat
Boston Partners Sells 690,421 Shares of Synchrony Financial $SYF - Defense World
Boston Partners Purchases 1,111 Shares of Wells Fargo & Company $WFC - Defense World
CocaCola Company (The) $KO Shares Purchased by Boston Partners - Defense World
Boston Partners Reduces Position in The Travelers Companies, Inc. $TRV - Defense World
Boston Partners Buys 525,214 Shares of Trimble Inc. $TRMB - Defense World
Zai Lab Ltd. Sponsored ADR (ZLAB) Stock Price Today | Live Chart & News - Traders Union
Can Zai Lab Limited (1ZLB) stock test all time highsQuarterly Portfolio Review & High Conviction Buy Zone Alerts - newser.com
EBITDA per share of Zai Lab Ltd. Sponsored ADR – SWB:1ZL - TradingView
UBS Lists CN Stocks w/ Highest Potential FY26 Earnings Upside (Table) - AASTOCKS.com
Zai Lab Ltd (1ZLB) Gets a Buy from UBS - The Globe and Mail
Zai Lab Limited (NASDAQ:ZLAB) Analysts Are Cutting Their Estimates: Here's What You Need To Know - simplywall.st
Analyst Forecasts Just Became More Bearish On Zai Lab Limited (NASDAQ:ZLAB) - simplywall.st
There is no doubt that Zai Lab Limited ADR (ZLAB) ticks all the boxes. - Setenews
Check Out Companhia Siderurgica Nacional ADR (SID)’s Trade Data Rather Than the Analysts’ Views - Setenews
symbol__ Stock Quote Price and Forecast - CNN
Zai Lab Limited Adr (ZLAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):